Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3580

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3580 9)

Atorvastatin Calcium 20 mg film-coated tablets packaging label from NuCare Pharmaceuticals, Inc. Contains 90 tablets. The label includes the NDC 68071-3580-9, manufacturer and repackager details, directions for use, and storage instructions to keep at controlled temperatures between 68-77°F. The product is prescription-only (Rx only).*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of atorvastatin calcium shown as a complex molecular diagram, including calcium ions and water molecules. The image depicts the arrangement of atoms and bonds characteristic of atorvastatin calcium in its hydrated form.*

FDA Label Image

Figure 1.jpg (Figure1)

A line graph comparing cumulative incidence percentages over time (in years) between atorvastatin and placebo groups. The graph shows a lower cumulative incidence for atorvastatin compared to placebo, with incidence increasing from 0 to about 3.5% over 3.5 years. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value indicating statistical comparison.*

FDA Label Image

Figure 2.jpg (Figure2)

A line graph showing cumulative hazard percentage over time for Atorvastatin and placebo groups, with time to first primary endpoint tracked over four years and hazard ratio (HR 0.63, 95% CI 0.48-0.83, p=0.001) indicated.*

FDA Label Image

Figure 3.jpg (Figure3)

A line graph comparing subjects (%) experiencing a major cardiovascular event over time (years) between two atorvastatin dosage groups, 10 mg (dashed line) and 80 mg (solid line). The x-axis represents time to first major cardiovascular endpoint up to 5 years, and the y-axis shows the percentage of subjects experiencing the event, ranging from 0 to 0.2. The graph includes a hazard ratio (HR 0.78) with confidence interval (0.69-0.89) and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.